Exact Mass: 457.2862
Exact Mass Matches: 457.2862
Found 147 metabolites which its exact mass value is equals to given mass value 457.2862
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
N-Docosahexaenoyl Glutamic acid
N-docosahexaenoyl glutamic acid belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Docosahexaenoyl amide of Glutamic acid. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Docosahexaenoyl Glutamic acid is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Docosahexaenoyl Glutamic acid is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
(1aR,1bR,2R,3S,3R,3aS,5R,5aS,5bS,6S,7aR,10aS,10bS,10cS)-1a,1b,23a,4,4,5,5,5a,5b,6,7,7a,9,10,10a,10b,10c-octadecahydro-3,5-dihydroxy-3,5a,6,7-tetramethylspiro[8H-benzo[1,2]fluoreno[ 3,4-b]oxirene-8,2(3H)-furo[3,2-b]pyridin]-6(3H)-one
Ile Ile Asn Val
Ile Ile Val Asn
Ile Lys Pro Thr
Ile Lys Thr Pro
Ile Leu Asn Val
Ile Leu Val Asn
Ile Asn Ile Val
Ile Asn Leu Val
Ile Asn Val Ile
Ile Asn Val Leu
Ile Pro Lys Thr
Ile Pro Thr Lys
Ile Gln Val Val
Ile Thr Lys Pro
Ile Thr Pro Lys
Ile Val Ile Asn
Ile Val Leu Asn
Ile Val Asn Ile
Ile Val Asn Leu
Ile Val Gln Val
Ile Val Val Gln
Lys Ile Pro Thr
Lys Ile Thr Pro
Lys Leu Pro Thr
Lys Leu Thr Pro
Lys Pro Ile Thr
Lys Pro Leu Thr
Lys Pro Thr Ile
Lys Pro Thr Leu
Lys Thr Ile Pro
Lys Thr Leu Pro
Lys Thr Pro Ile
Lys Thr Pro Leu
Leu Ile Asn Val
Leu Ile Val Asn
Leu Lys Pro Thr
Leu Lys Thr Pro
Leu Leu Asn Val
Leu Leu Val Asn
Leu Asn Ile Val
Leu Asn Leu Val
Leu Asn Val Ile
Leu Asn Val Leu
Leu Pro Lys Thr
Leu Pro Thr Lys
Leu Gln Val Val
Leu Thr Lys Pro
Leu Thr Pro Lys
Leu Val Ile Asn
Leu Val Leu Asn
Leu Val Asn Ile
Leu Val Asn Leu
Leu Val Gln Val
Leu Val Val Gln
Asn Ile Ile Val
Asn Ile Leu Val
Asn Ile Val Ile
Asn Ile Val Leu
Asn Leu Ile Val
Asn Leu Leu Val
Asn Leu Val Ile
Asn Leu Val Leu
Asn Val Ile Ile
Asn Val Ile Leu
Asn Val Leu Ile
Asn Val Leu Leu
Pro Ile Lys Thr
Pro Ile Thr Lys
Pro Lys Ile Thr
Pro Lys Leu Thr
Pro Lys Thr Ile
Pro Lys Thr Leu
Pro Leu Lys Thr
Pro Leu Thr Lys
Pro Thr Ile Lys
Pro Thr Lys Ile
Pro Thr Lys Leu
Pro Thr Leu Lys
Gln Ile Val Val
Gln Leu Val Val
Gln Val Ile Val
Gln Val Leu Val
Gln Val Val Ile
Gln Val Val Leu
Thr Ile Lys Pro
Thr Ile Pro Lys
Thr Lys Ile Pro
Thr Lys Leu Pro
Thr Lys Pro Ile
Thr Lys Pro Leu
Thr Leu Lys Pro
Thr Leu Pro Lys
Thr Pro Ile Lys
Thr Pro Lys Ile
Thr Pro Lys Leu
Thr Pro Leu Lys
Val Ile Ile Asn
Val Ile Leu Asn
Val Ile Asn Ile
Val Ile Asn Leu
Val Ile Gln Val
Val Ile Val Gln
Val Leu Ile Asn
Val Leu Leu Asn
Val Leu Asn Ile
Val Leu Asn Leu
Val Leu Gln Val
Val Leu Val Gln
Val Asn Ile Ile
Val Asn Ile Leu
Val Asn Leu Ile
Val Asn Leu Leu
Val Gln Ile Val
Val Gln Leu Val
Val Gln Val Ile
Val Gln Val Leu
Val Val Ile Gln
Val Val Leu Gln
Val Val Gln Ile
Val Val Gln Leu
Nevanimibe hydrochloride
C471 - Enzyme Inhibitor Nevanimibe hydrochloride (PD-132301 hydrochloride) is an orally active and selective acyl-coenzyme A:cholesterol O-acyltransferase 1 (ACAT1) inhibitor with an EC50 of 9 nM. Nevanimibe hydrochloride inhibits ACAT2 with an EC50 of 368 nM. Nevanimibe hydrochloride induces cell apoptosis and has the potential for adrenocortical cancer[1].
2-[[(4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoyl]amino]pentanedioic acid
(4E,8E,12E)-2-(decanoylamino)-3-hydroxytetradeca-4,8,12-triene-1-sulfonic acid
N-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-L-glutamic acid
An N-(long-chain-fatty-acyl)-L-glutamic acid in which the acyl group is specified as (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl.